MedPath

Chungnam National University Hospital

🇰🇷South Korea
Ownership
Private
Established
1972-01-01
Employees
-
Market Cap
-
Website
http://www.cnuh.co.kr

Clinical Trials

118

Active:10
Completed:50

Trial Phases

2 Phases

Phase 2:3
Not Applicable:105

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (108 trials with phase data)• Click on a phase to view related trials

Not Applicable
105 (97.2%)
Phase 2
3 (2.8%)

Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients

Conditions
HIV
Interventions
Drug: DTG + 3TC FDC
First Posted Date
2025-04-15
Last Posted Date
2025-04-15
Lead Sponsor
Chungnam National University Hospital
Target Recruit Count
200
Registration Number
NCT06928090
Locations
🇰🇷

Chungnam National University Hospital, 282 Munwha-ro, Daejeon, Korea, Republic of

A Comparative Analysis of Preoperative Liver Volumetry in Living Donor Liver Transplantation

Completed
Conditions
Living Donor Liver Transplantation
Liver Failure
First Posted Date
2025-03-10
Last Posted Date
2025-03-10
Lead Sponsor
Chungnam National University Hospital
Target Recruit Count
109
Registration Number
NCT06865612
Locations
🇰🇷

Chungnam National University Hospital, Daejeon, Korea, Republic of

Drug Response Testing and Repurposing Using Glioblastoma Organoid

Recruiting
Conditions
Glioblastoma
Organoid
First Posted Date
2025-01-20
Last Posted Date
2025-01-20
Lead Sponsor
Chungnam National University Hospital
Target Recruit Count
150
Registration Number
NCT06782984
Locations
🇰🇷

Chungnam National University Hospital, Daejeon, Chungnam, Korea, Republic of

Biliary Complication Rates in Living Donor Liver Transplantation: a Retrospective Comparative Study of Stent Versus Non-Stent Groups

Active, not recruiting
Conditions
Liver Failure
Living Donor Liver Transplantation
Biliary Complications
Biliary Stents
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
Chungnam National University Hospital
Target Recruit Count
160
Registration Number
NCT06767553
Locations
🇰🇷

Chungnam National University Hospital, Daejeon, Korea, Republic of

Tapering Heart Failure Medication in Patients with Heart Failure with Recovered Ejection Fraction; Open Label Prospective Random Trial

Not Applicable
Not yet recruiting
Conditions
Heart Failure
Ejection Fraction
Recovery of Function
Interventions
Drug: Beta blocker tapering out
First Posted Date
2024-12-09
Last Posted Date
2024-12-09
Lead Sponsor
Chungnam National University Hospital
Target Recruit Count
150
Registration Number
NCT06724653
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath